title: Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression.
abstract: In contrast to relapse, the mechanisms of multiple sclerosis (MS) disease progression are less understood and appear not to be exclusively inflammatory in nature. In this pilot study we investigated the relationship between disturbed CNS energy metabolism and MS disease progression. We tested the hypothesis that cerebrospinal fluid (CSF) concentrations of sorbitol, fructose, and lactate, all metabolites of extra-mitochondrial glucose metabolism, would be elevated in secondary progressive (SP) MS patients and would be associated with worsening neurologic disability. We measured metabolite concentrations by gas chromatographic/mass spectrometric and enzymatic methods in archived CSF samples from 85 MS patients [31 relapsing-remitting (RR) and 54 SP patients] and 18 healthy controls. We found that concentrations of all three metabolites, but not concentrations of glucose or myoinositol, were significantly increased in CSF from SP and, to a lesser degree, RR patients, compared to controls. Furthermore, CSF concentrations of sorbitol and fructose (polyol pathway metabolites), but not lactate (anaerobic glycolysis metabolite), correlated positively and significantly with Expanded Disability Status Scale (EDSS) score, an index of neurologic disability in MS patients. We conclude that extra-mitochondrial glucose metabolism is increased in MS patients and is associated with disease progression evidenced by increasing EDSS score. As extra-mitochondrial glucose metabolism increases with impaired mitochondrial metabolism of glucose, these findings implicate mitochondrial dysfunction in the pathogenesis of MS disease progression. CSF metabolic profiling may be useful in clarifying the role of mitochondrial pathology in progression and in targeting and monitoring therapies for disease progression that aim to preserve or boost mitochondrial glucose metabolism.
authors.affiliation: University of Maryland School of Medicine, Department of Psychiatry, Division of Geriatric Psychiatry, Baltimore, MD 21201, USA. wregenol@psych.umaryland.edu
authors.forename: William T
authors.initials: WT
authors.lastname: Regenold
authors.forename: Pornima
authors.initials: P
authors.lastname: Phatak
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Makley
authors.forename: Roger D
authors.initials: RD
authors.lastname: Stone
authors.forename: Mitchel A
authors.initials: MA
authors.lastname: Kling
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D018450:Disease Progression; D005260:Female; D005632:Fructose / Q000134:cerebrospinal fluid; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D019344:Lactic Acid / Q000134:cerebrospinal fluid; D008297:Male; D008875:Middle Aged; D008928:Mitochondria / Q000378:metabolism*; D028361:Mitochondrial Diseases / Q000209:etiology* / Q000473:pathology; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid* / Q000145:classification / Q000150:complications*; D010865:Pilot Projects; D013012:Sorbitol / Q000134:cerebrospinal fluid; D055815:Young Adult
chemical_list: D005632:Fructose; D019344:Lactic Acid; D013012:Sorbitol; D005947:Glucose
references.citation: Neuromolecular Med. 2003;3(3):147-58
references.pmid: 12835510
references.citation: J Neurol Neurosurg Psychiatry. 1964 Oct;27:415-21
references.pmid: 14213470
references.citation: Diabetologia. 1966 Sep;2(2):82-5
references.pmid: 6005214
references.citation: J Chromatogr. 1984 Dec 12;336(2):351-5
references.pmid: 6530467
references.citation: Brain. 1988 Oct;111 ( Pt 5):1009-24
references.pmid: 3263167
references.citation: Eur J Pediatr. 1995;154(7 Suppl 2):S53-64
references.pmid: 7671966
references.citation: Eur J Neurol. 2007 Jan;14(1):44-7
references.pmid: 17222112
references.citation: Philos Trans R Soc Lond B Biol Sci. 1999 Jul 29;354(1387):1155-63
references.pmid: 10466143
references.citation: J Neurosurg. 1989 Feb;70(2):183-9
references.pmid: 2913216
references.citation: Clin Chem. 1996 Feb;42(2):298-302
references.pmid: 8595727
references.citation: Can J Neurol Sci. 1993 Aug;20(3):194-8
references.pmid: 8221382
references.citation: J Biol Chem. 2006 Oct 20;281(42):31950-62
references.pmid: 16920708
references.citation: N Engl J Med. 2000 Nov 16;343(20):1486-7
references.pmid: 11078776
references.citation: Acta Endocrinol Suppl (Copenh). 1980;238:133-7
references.pmid: 6933810
references.citation: Acta Neurol Scand. 1997 Jan;95(1):9-12
references.pmid: 9048978
references.citation: Acta Neurol Scand. 1977 Aug;56(2):104-10
references.pmid: 899714
references.citation: J Affect Disord. 2005 Apr;85(3):341-50
references.pmid: 15780705
references.citation: J Neurol Sci. 1996 Dec;144(1-2):182-90
references.pmid: 8994122
references.citation: J Clin Invest. 1995 Feb;95(2):542-6
references.pmid: 7860736
references.citation: Psychoneuroendocrinology. 2000 Aug;25(6):593-606
references.pmid: 10840171
references.citation: N Engl J Med. 2000 Nov 16;343(20):1430-8
references.pmid: 11078767
references.citation: Nat Med. 2007 Dec;13(12):1483-9
references.pmid: 17994101
references.citation: Acta Neurol Scand. 1998 Oct;98(4):232-7
references.pmid: 9808271
references.citation: Neurology. 2004 Apr 27;62(8):1297-302
references.pmid: 15111665
references.citation: Annu Rev Med. 1975;26:521-36
references.pmid: 238458
references.citation: J Neuroimmunol. 2007 Aug;188(1-2):1-12
references.pmid: 17493689
references.citation: Acta Med Austriaca. 2001;28(5):152-5
references.pmid: 11774778
references.citation: PLoS One. 2007 Jul 04;2(7):e595
references.pmid: 17611627
references.citation: Acta Neurol Scand. 1989 Dec;80(6):561-8
references.pmid: 2515713
references.citation: J Neurol Neurosurg Psychiatry. 1997 Mar;62(3):290
references.pmid: 9069491
references.citation: J Pediatr. 2001 Feb;138(2):260-2
references.pmid: 11174626
references.citation: J Cereb Blood Flow Metab. 2001 Jan;21(1):85-91
references.pmid: 11149672
references.citation: C R Acad Sci III. 1996 Jul;319(7):623-31
references.pmid: 9011324
references.citation: J Neurol Sci. 2000 Aug 15;177(2):95-103
references.pmid: 10980305
references.citation: Diabet Med. 1995 Jul;12(7):566-79
references.pmid: 7554777
references.citation: Anal Biochem. 1995 Jan 1;224(1):279-85
references.pmid: 7710082
references.citation: Clin Chem. 1995 Mar;41(3):343-60
references.pmid: 7882508
references.citation: Brain. 2005 May;128(Pt 5):1026-37
references.pmid: 15728653
references.citation: Neurology. 1970 May;20(5):1-59
references.pmid: 4314823
references.citation: J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):446-51
references.pmid: 9343121
references.citation: Acta Neurol Scand. 1995 May;91(5):326-9
references.pmid: 7639060
references.citation: Ann Neurol. 1999 Dec;46(6):925-8
references.pmid: 10589548
references.citation: Ann Neurol. 2006 Mar;59(3):478-89
references.pmid: 16392116
references.citation: Mult Scler. 1995 Apr;1(1):32-6
references.pmid: 9345467
references.citation: Trends Mol Med. 2006 May;12(5):192-5
references.pmid: 16574486